UBS Group’s Stealth BioTherapeutics Corp. ADS MITO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-487
| Closed | – | – | 10484 |
|
|
2022
Q3 | $0 | Sell |
487
-28,032
| -98% | – | ﹤0.01% | 10321 |
|
|
2022
Q2 | $7K | Buy |
28,519
+26,940
| +1,706% | +$6.61K | ﹤0.01% | 7571 |
|
|
2022
Q1 | $1K | Buy |
1,579
+1,092
| +224% | +$692 | ﹤0.01% | 9037 |
|
|
2021
Q4 | $0 | Hold |
487
| – | – | ﹤0.01% | 9789 |
|
|
2021
Q3 | $1K | Sell |
487
-14,820
| -97% | -$30.4K | ﹤0.01% | 8237 |
|
|
2021
Q2 | $24K | Buy |
15,307
+10,537
| +221% | +$16.5K | ﹤0.01% | 6083 |
|
|
2021
Q1 | $8K | Buy |
4,770
+4,083
| +594% | +$6.85K | ﹤0.01% | 7085 |
|
|
2020
Q4 | $1K | Sell |
687
-7,115
| -91% | -$10.4K | ﹤0.01% | 7259 |
|
|
2020
Q3 | $11K | Sell |
7,802
-7,198
| -48% | -$10.1K | ﹤0.01% | 5929 |
|
|
2020
Q2 | $27K | Buy |
15,000
+14,600
| +3,650% | +$26.3K | ﹤0.01% | 5515 |
|
|
2020
Q1 | $1K | Sell |
400
-6,600
| -94% | -$16.5K | ﹤0.01% | 6925 |
|
|
2019
Q4 | $23K | Buy |
7,000
+286
| +4% | +$940 | ﹤0.01% | 5738 |
|
|
2019
Q3 | $40K | Buy |
6,714
+4,633
| +223% | +$27.6K | ﹤0.01% | 5375 |
|
|
2019
Q2 | $26K | Buy |
2,081
+2,016
| +3,102% | +$25.2K | ﹤0.01% | 5579 |
|
|
2019
Q1 | $1K | Buy |
+65
| New | +$1K | ﹤0.01% | 6760 |
|